insights_auto
为什么 MANKIND 下跌了 3.07%?
深入探索chevron_right
MANKIND:NSE
Mankind Pharma Ltd
₹2,275.50
arrow_downward
-3.07%(-72.10) 1 天
10月16日, GMT+5:30 15:30:00 · INR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 MANKIND 生成关键数据洞见…
开盘价
₹2,349.90
最高价
₹2,354.40
最低价
₹2,268.70
市值
9373.99亿
平均成交量
48.40万
成交量
88.97万
市盈率
46.04
52 周最高价
₹2,642.00
52 周最低价
₹1,909.70
每股收益
₹49.42
员工人数
2万
开盘价
₹2,349.90
最高价
₹2,354.40
最低价
₹2,268.70
市值
9373.99亿
平均成交量
48.40万
成交量
88.97万
市盈率
46.04
52 周最高价
₹2,642.00
52 周最低价
₹1,909.70
每股收益
₹49.42
员工人数
2万
新闻报道
来自网络来源和新闻合作伙伴
Traders Union
·
2天前
投资者撤离科技股，标普500指数期货上涨
VT Markets
·
2天前
标普500指数回升：医疗保健板块上涨抵消AI概念股抛售压力
资料
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Mankind Pharma Ltd简介